Terms: = Colorectal cancer AND MYH9, P35579, 4627, ENSG00000100345, DFNA17 AND Treatment
4 results:
1. Machine learning with in silico analysis markedly improves survival prediction modeling in colon cancer patients.
Lee CJ; Baek B; Cho SH; Jang TY; Jeon SE; Lee S; Lee H; Nam JS
Cancer Med; 2023 Mar; 12(6):7603-7615. PubMed ID: 36345155
[TBL] [Abstract] [Full Text] [Related]
2. Long-term effects of laparoscopic lateral pelvic lymph node dissection on urinary retention in rectal cancer.
Sadakari Y; Hisano K; Sada M; Mizuuchi Y; Nagayoshi K; Fujita H; Nagai S; Manabe T; Ueki T; Nakamura M
Surg Endosc; 2022 Feb; 36(2):999-1007. PubMed ID: 33616731
[TBL] [Abstract] [Full Text] [Related]
3. Single-agent capecitabine as maintenance therapy after induction of XELOX (or FOLFOX) in first-line treatment of metastatic colorectal cancer: randomized clinical trial of efficacy and safety.
Luo HY; Li YH; Wang W; Wang ZQ; Yuan X; Ma D; Wang FH; Zhang DS; Lin DR; Lin YC; Jia J; Hu XH; Peng JW; Xu RH
Ann Oncol; 2016 Jun; 27(6):1074-1081. PubMed ID: 26940686
[TBL] [Abstract] [Full Text] [Related]
4. Dose- and time-dependent gene expression alterations in prostate and colon cancer cells after in vitro exposure to carbon ion and X-irradiation.
Suetens A; Moreels M; Quintens R; Soors E; Buset J; Chiriotti S; Tabury K; Gregoire V; Baatout S
J Radiat Res; 2015 Jan; 56(1):11-21. PubMed ID: 25190155
[TBL] [Abstract] [Full Text] [Related]
